716-1103

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
716 (USA) · Dr. Ito
consented 2014-03-20

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate BLISTER — outcome: RECOVERED/RESOLVED; onset 2014-07-09 (study day 112.0); relationship: PROBABLE

severe assessed

Severe BLISTER — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-08-17 (study day 151.0); relationship: PROBABLE

severe assessed

Severe BLISTER — outcome: RECOVERED/RESOLVED; onset 2014-08-17 (study day 151.0); relationship: PROBABLE

moderate assessed

Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-09 (study day 112.0); relationship: PROBABLE

moderate assessed

Moderate PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2014-07-09 (study day 112.0); relationship: PROBABLE

Data queries

No data queries.